APP-H4 cells, a human neuroglioma line genetically modified to overexpress amyloid precursor protein (APP), are a valuable tool for AD research, such as studies on the mechanisms of Aβ production and processing, as well as the evaluation of therapeutic candidates [28]. The gene discussed is APP; the disease is Alzheimer disease.